ST Pharm Co.,Ltd. (KOSDAQ:237690)

ST Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,037,259	1,790,029	1,275,235	1,647,649	2,596,915	1,936,493
Market Cap Growth	62.05%	40.37%	-22.60%	-36.55%	34.10%	248.32%
Enterprise Value	2,997,235	1,811,053	1,375,695	1,714,024	2,628,966	1,910,417
Last Close Price	146700.00	88900.00	67410.34	86388.45	136510.46	101442.21
PE Ratio	81.72	51.57	65.13	91.54	784.06	-
Forward PE	48.77	36.22	37.69	67.19	133.19	-
PS Ratio	9.54	6.54	4.47	6.61	15.68	15.60
PB Ratio	5.46	3.56	3.30	4.83	7.97	6.53
P/TBV Ratio	5.63	3.68	3.44	5.07	8.37	6.79
P/FCF Ratio	202.44	67.18	-	-	-	-
P/OCF Ratio	33.42	16.36	982.17	234.34	357.22	-
EV/Sales Ratio	9.42	6.62	4.83	6.88	15.87	15.39
EV/EBITDA Ratio	37.81	33.99	24.33	48.35	131.50	-
EV/EBIT Ratio	58.54	65.40	41.05	96.02	471.35	-
EV/FCF Ratio	199.77	67.97	-	-	-	-
Debt / Equity Ratio	0.14	0.24	0.50	0.39	0.33	0.43
Debt / EBITDA Ratio	1.01	2.22	3.40	3.79	5.38	-
Debt / FCF Ratio	5.33	4.43	-	-	-	-
Asset Turnover	0.44	0.39	0.46	0.47	0.35	0.32
Inventory Turnover	1.16	1.46	1.54	1.72	1.75	2.45
Quick Ratio	0.96	1.43	2.53	0.82	3.00	10.07
Current Ratio	2.04	2.48	4.16	1.47	4.64	12.66
Return on Equity (ROE)	6.89%	7.30%	4.81%	5.25%	1.08%	-4.38%
Return on Assets (ROA)	4.44%	2.48%	3.36%	2.09%	0.74%	-2.99%
Return on Invested Capital (ROIC)	7.24%	4.25%	5.50%	4.25%	1.79%	-7.00%
Return on Capital Employed (ROCE)	8.90%	4.70%	5.70%	4.60%	1.30%	-4.40%
Earnings Yield	1.21%	1.94%	1.54%	1.09%	0.13%	-0.63%
FCF Yield	0.49%	1.49%	-3.29%	-3.24%	-1.71%	-1.96%
Dividend Yield	0.34%	0.56%	-	-	-	-
Payout Ratio	27.31%	27.09%	48.03%	52.25%	-	-
Buyback Yield / Dilution	-7.23%	-3.70%	-	-0.77%	-0.05%	-
Total Shareholder Return	-6.89%	-3.13%	-	-0.77%	-0.05%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.